Digestive discomfort has many of us running to the medicine cabinet at an amazing rate. The market for antacids alone has grown to $9.12 billion in 2022 globally from $8.6 billion in 2021, according to market intelligence firm ReportLinker.
Just in North America, the market is valued at $5.15 billion in 2022, with an expected compound annual growth rate of 4.6 percent as assessed by Market Data Forecast. Notable pharmaceutical companies, including GlaxoSmithKline, Pfizer, Bayer, and AstraZeneca, are key market players in the growth of the antacid market.
